ArticleFrontiers in bioengineering and biotechnology2025

Corrigendum: Advances in Doxorubicin-based nano-drug delivery system in triple negative breast cancer.

Weiwei Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.